Sally Ellis

5.2k total citations
44 papers, 1.3k citations indexed

About

Sally Ellis is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Sally Ellis has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 16 papers in Epidemiology and 14 papers in Pharmacology. Recurrent topics in Sally Ellis's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Use and Resistance (10 papers) and Neonatal and Maternal Infections (10 papers). Sally Ellis is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Use and Resistance (10 papers) and Neonatal and Maternal Infections (10 papers). Sally Ellis collaborates with scholars based in United Kingdom, Switzerland and United States. Sally Ellis's co-authors include Mike Sharland, Manica Balasegaram, Ramesh Agarwal, Suman Chaurasia, Sindhu Sivanandan, M. Jeeva Sankar, Yingfen Hsia, Julia Bielicki, Nathalie Strub‐Wourgaft and F. Franceschi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sally Ellis

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sally Ellis United Kingdom	19	670	568	244	213	196	44	1.3k
Leonard B. Johnson United States	27	484 0.7×	1.2k 2.1×	197 0.8×	284 1.3×	110 0.6×	90	2.7k
Sonal S. Munsiff United States	25	165 0.2×	1.6k 2.9×	118 0.5×	126 0.6×	51 0.3×	68	2.8k
Pilar Ramón-Pardo United States	13	424 0.6×	271 0.5×	224 0.9×	66 0.3×	240 1.2×	37	1.6k
Dante Bassetti Italy	20	147 0.2×	379 0.7×	65 0.3×	132 0.6×	76 0.4×	72	1.3k
Mark D. King United States	13	590 0.9×	539 0.9×	174 0.7×	158 0.7×	163 0.8×	18	2.2k
Kathryn Como‐Sabetti United States	16	740 1.1×	482 0.8×	122 0.5×	79 0.4×	146 0.7×	34	1.9k
Wendy Baughman United States	19	341 0.5×	2.2k 3.8×	121 0.5×	140 0.7×	132 0.7×	21	2.7k
Sanjay Bhattacharya India	18	87 0.1×	326 0.6×	387 1.6×	84 0.4×	239 1.2×	94	1.2k
S. J. van Hal Australia	18	365 0.5×	655 1.2×	221 0.9×	553 2.6×	177 0.9×	20	2.4k
Elias B. Chahine United States	18	74 0.1×	335 0.6×	203 0.8×	204 1.0×	187 1.0×	74	1.1k

Countries citing papers authored by Sally Ellis

Since Specialization

Citations

This map shows the geographic impact of Sally Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Ellis more than expected).

Fields of papers citing papers by Sally Ellis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Ellis. The network helps show where Sally Ellis may publish in the future.

Co-authorship network of co-authors of Sally Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Ellis. A scholar is included among the top collaborators of Sally Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Ellis. Sally Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shearer, Freya M., James M. McCaw, Gerard E. Ryan, et al.. (2024). Estimating the impact of test–trace–isolate–quarantine systems on SARS-CoV-2 transmission in Australia. Epidemics. 47. 100764–100764. 3 indexed citations

Turner, Rebecca, A. Sarah Walker, Sally Ellis, et al.. (2024). Determining sample size in a personalized randomized controlled (PRACTical) trial. Statistics in Medicine. 43(21). 4098–4112. 2 indexed citations

Guindo, Ousmane, et al.. (2023). Practices and challenges related to antibiotic use in paediatric treatment in hospitals and health centres in Niger and Uganda: a mixed methods study. Antimicrobial Resistance and Infection Control. 12(1). 67–67. 13 indexed citations

Howard‐Jones, Annaleise R., Alicia Arnott, Jenny Draper, et al.. (2023). Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severity. International Journal of Infectious Diseases. 130. 38–41.

Obiero, Christina W., Phoebe Williams, Johnstone Thitiri, et al.. (2022). Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overload. Archives of Disease in Childhood. 107(9). 802–810. 13 indexed citations

McEntee, Laura, Adam Johnson, Nicola Farrington, et al.. (2022). Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings. Journal of Antimicrobial Chemotherapy. 77(12). 3349–3357. 3 indexed citations

Farrington, Nicola, Adam Johnson, Laura McEntee, et al.. (2022). Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance. Journal of Antimicrobial Chemotherapy. 77(5). 1334–1343. 10 indexed citations

Scudeller, Luigia, Elda Righi, Damiano Bragantini, et al.. (2021). Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International Journal of Antimicrobial Agents. 57(5). 106344–106344. 74 indexed citations

Docobo-Pérez, Fernando, Nicola Farrington, Adam Johnson, et al.. (2021). Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance. Antimicrobial Agents and Chemotherapy. 65(7). e0029321–e0029321. 15 indexed citations

10.

Carrara, Elena, Alessia Savoldi, Laura J. V. Piddock, et al.. (2021). Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations. Clinical Microbiology and Infection. 28(1). 66–72. 15 indexed citations

11.

Savoldi, Alessia, Elena Carrara, Laura J. V. Piddock, et al.. (2021). The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies. BMC Infectious Diseases. 21(1). 545–545. 26 indexed citations

12.

Chaurasia, Suman, Sindhu Sivanandan, Ramesh Agarwal, et al.. (2019). Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance. BMJ. 364. k5314–k5314. 152 indexed citations

13.

Goyal, Vishal, Raman Mahajan, Krishna Pandey, et al.. (2018). Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India. PLoS neglected tropical diseases. 12(10). e0006830–e0006830. 16 indexed citations

14.

Rahman, Ridwanur, Vishal Goyal, Rashidul Haque, et al.. (2017). Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh. PLoS neglected tropical diseases. 11(5). e0005635–e0005635. 55 indexed citations

15.

Dillon, Magnus T., Aude Espinasse, Sally Ellis, et al.. (2017). A Phase I dose-escalation study of ATR inhibitor monotherapy with AZD6738 in advanced solid tumors (PATRIOT Part A). UCL Discovery (University College London). 1 indexed citations

16.

Folgori, Laura, Sally Ellis, Julia Bielicki, et al.. (2017). Tackling antimicrobial resistance in neonatal sepsis. The Lancet Global Health. 5(11). e1066–e1068. 44 indexed citations

17.

Basmaci, Romain, Julia Bielicki, Ron Daniels, et al.. (2017). Management of children with multidrug-resistant sepsis in low-income and middle-income countries. The Lancet Child & Adolescent Health. 2(1). 8–10. 6 indexed citations

18.

Sundar, Shyam, Prabhat Kumar Sinha, Madhukar Rai, et al.. (2011). Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. The Lancet. 377(9764). 477–486. 239 indexed citations

19.

Edwards, Tansy, Raymond Omollo, Eltahir Awad Gasim Khalil, et al.. (2011). Single-dose liposomal amphotericin B (AmBisome®) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials. 12(1). 66–66. 8 indexed citations

20.

Ellis, Sally, et al.. (2003). Assessment of Adrenal Suppression from Two New Dry Powder Inhaler Formulations of Budesonide Delivered by Clickhaler ^® Compared with the Pulmicort ^® Turbuhaler ^®. Journal of Aerosol Medicine. 16(1). 31–36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact